Test Price
20,000 AED✅ Home Collection Available
Human Bisulfite Sequencing and Methylation Analysis in UAE | 20000 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed specialists.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
- Price: 20,000 AED inclusive of analysis and comprehensive clinical report.
- Turnaround Time: 10 weeks for full genome-wide methylation interpretation.
Test Overview & Methodology
This advanced bisulfite sequencing panel decodes genome-wide DNA methylation patterns at single-base resolution, empowering oncologists, rheumatologists, and functional medicine practitioners to detect early malignant transformations, assess autoimmune disease risk, and tailor anti-aging protocols. Using next-generation sequencing (NGS) combined with bisulfite conversion chemistry, it delivers a complete methylation landscape critical for precision medicine. The analysis is performed in our DHA-licensed laboratory facility under strict ISO quality controls.
| Feature | Our Test (Human Bisulfite Sequencing) | Closest Alternative (Methylation Array) |
|---|---|---|
| Precision | Single‑cytosine resolution across millions of CpG sites | Bulk signal from predefined probes (~850k CpGs) |
| Methodology | Bisulfite conversion + NGS with advanced bioinformatics | Hybridization‑based BeadChip array |
| Genome Coverage | Whole‑genome unbiased coverage | Targeted probe set only |
| Turnaround Time | 10 weeks (comprehensive interpretation) | 4–6 weeks |
Physician Insight & Safety Protocols
“Epigenetic profiling through bisulfite sequencing offers an unprecedented window into the molecular mechanisms driving disease. This test reveals your unique DNA methylation blueprint, enabling early detection of epigenetic alterations associated with malignancy and autoimmune conditions. Patients should understand that results must always be interpreted alongside a complete clinical history and physical examination.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication & Health Advisory
⚠️ Important Medication Notice
Do not discontinue or alter any prescribed medications without consulting your referring physician or the DHA-licensed clinical genetics team. Epigenetic test results may inform future therapeutic adjustments but should never replace current treatment protocols.
Patient Safety Exclusion Criteria & Urgent Alerts
- Exclusion: Active hemolysis, severe local infection at venipuncture site, or known bleeding disorder without medical clearance.
- Exclusion: Minors must be accompanied by a legal guardian and provide written informed consent as per UAE Federal Decree-Law No. 4 of 2016 on Medical Liability.
- ER Red Flag: If you experience unexplained weight loss, persistent fever, severe joint pain, palpable masses, or night sweats, seek immediate emergency care; this test is not a substitute for acute medical evaluation.
Patient FAQ & Clinical Guidance
1. What is human bisulfite sequencing and why is it performed?
Human bisulfite sequencing measures DNA methylation patterns across the entire genome at single-base resolution. It is performed to detect epigenetic changes linked to cancer, autoimmune disorders, and biological aging. Oncologists use it for early tumor detection, rheumatologists for disease activity monitoring, and functional medicine practitioners to design personalised wellness strategies. This test provides a comprehensive methylation map that standard arrays cannot match.
2. How should I prepare for the sample collection?
Preparation is minimal. No fasting is required; maintain normal hydration and continue all prescribed medications unless your physician instructs otherwise. Whole blood or previously extracted DNA samples are accepted. Our VIP mobile phlebotomy team will handle cold-chain transport according to ISO standards between 8 AM and 11 PM daily.
3. What do my results mean and will I receive clinical guidance?
Your comprehensive report categorises methylation patterns as normal, borderline, or aberrant, and includes actionable recommendations reviewed by our DHA-licensed clinical genetics team. A telephonic consultation with a Consultant Medical Geneticist is included to explain the findings and discuss any necessary follow-up with your referring physician.
4. How long does it take to receive my results?
The complete analysis and interpretation cycle requires 10 weeks due to the complexity of genome-wide bisulfite sequencing, bioinformatics processing, and clinical validation. You will be notified once the report is ready for download or courier delivery.
5. Is the test covered by insurance in the UAE?
Coverage varies by insurer and policy. Our team can verify your direct billing eligibility via WhatsApp at +971 54 548 8731. We accept major UAE health insurance plans and provide detailed invoices for reimbursement submissions.
UAE Regulatory & Data Privacy Adherence
Compliance Framework
- Data Protection: All genetic and methylation data are processed and stored in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Health Information Governance: Operates under Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Medical Liability: Patient consent and clinical safety protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Laboratory Accreditation: ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139) with strict internal quality controls.
Clinical & Logistical Metadata
| Test Name | Human Bisulfite Sequencing and Methylation Analysis |
| Price (AED) | 20,000 AED |
| Turnaround Time | 10 weeks |
| Sample Type / Matrix | Whole Blood or Extracted DNA (EDTA tube) |
| Methodology Used | Bisulfite Conversion + Next-Generation Sequencing (NGS) with Bioinformatics Interpretation |
| ICD-10-CM Code | Z13.89 (Encounter for screening for other disorder) |
| LOINC Code | 95451-5 (DNA methylation analysis) |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians